Apex Capital Management’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$58.8M Buy
1,277,879
+22,436
+2% +$814K 1.29% 17
2015
Q4
$60.7M Sell
1,255,443
-6,664
-0.5% -$288K 1.36% 18
2015
Q3
$53.6M Buy
1,262,107
+43,273
+4% +$2.14M 1.21% 27
2015
Q2
$69.6M Buy
1,218,834
+60,090
+5% +$3.7M 1.49% 13
2015
Q1
$74.8M Buy
1,158,744
+56,242
+5% +$3.22M 1.76% 7
2014
Q4
$54.9M Buy
1,102,502
+230,562
+26% +$12M 1.46% 19
2014
Q3
$43.1M Buy
871,940
+301,126
+53% +$12.8M 1.3% 24
2014
Q2
$22M Buy
570,814
+58,938
+12% +$1.99M 0.68% 63
2014
Q1
$16.5M Buy
511,876
+25,210
+5% +$930K 0.58% 62
2013
Q4
$15.5M Buy
+486,666
New +$14.7M 0.58% 64

Other funds holding MDVN

Apex Capital Management's MDVN Position: Q1 2016 in Review

Apex Capital Management increased its MEDIVATION, INC. (MDVN) stake by 1.8% in Q1 2016, buying an estimated $814K and bringing the position to 1,277,879 shares worth $58.8M. The position accounts for 1.29% of the portfolio, ranked #17.

Apex Capital Management first reported a position in MDVN in Q4 2013 and has held it in 10 quarters since. The position peaked at $74.8M in Q1 2015. 360 funds tracked by Wall St. Rank hold MDVN as of Q1 2016.

  • Apex Capital Management held 1,277,879 shares of MEDIVATION, INC. worth $58.8M as of Q1 2016.
  • Apex Capital Management bought 22,436 MEDIVATION, INC. shares in Q1 2016, an estimated $814K.
  • MEDIVATION, INC. made up 1.29% of Apex Capital Management's portfolio in Q1 2016, its #17 holding.
  • Apex Capital Management first reported a position in MEDIVATION, INC. in Q4 2013 and has held it in 10 quarters since.
  • Apex Capital Management's MEDIVATION, INC. position peaked at $74.8M in Q1 2015.
  • 360 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.